Manzo Pharmaceuticals

(OTC) MNZO

Current Price$0.00

Market Cap$937.50K

Since IPO (1992)-100%

5 Year+0%

1 Year+0%

1 Month+0%

Manzo Pharmaceuticals Financials at a Glance

Market Cap

$937.50K

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

14.63 (High)

Dividend

$0.00

Beta (Volatility)

14.63 (High)

Price

$0.00

Volume

169,100

Open

$0.00

Price

$0.00

Volume

169,100

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

14.63 (High)

Price

$0.00

Volume

169,100

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

MNZO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Manzo Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

CEO

Arthur Douglas Smitherman

Website

www.manzopharma.com

Headquarters

Milford, PA 18337, US

MNZO Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-26%

Return on Assets

-26%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$937.50K

Shares Outstanding

9.37B

Volume

169.10K

Avg. Volume

57.67K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$52.15K

EBITDA

-$52.15K

Operating Cash Flow

-$50.85K

Capital Expenditure

-$52.00K

Free Cash Flow

-$102.85K

Cash & ST Invst.

$12.31K

Total Debt

-$11.09K

Manzo Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2005YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$937.50K

N/A

Market Cap/Employee

$78.13K

N/A

Employees

N/A

Net Income

-$1.23M

N/A

EBITDA

$27.89K

N/A

Quarterly Fundamentals

Name

Q3 2005YOY CHG

Total Cash

$6.91K

N/A

Total Debt

$5.12M

N/A

Accounts Receivable

$2.68M

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$5.12M

N/A

Return on Assets

-26.43%

N/A

Return on Invested Capital

-25.63%

N/A

Free Cash Flow

-$608.34K

N/A

Operating Cash Flow

-$608.34K

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VNTAVentana Biotech, Inc.

VNTAVentana Biotech, Inc.$0.06+59.46%

LTUSLotus Pharmaceuticals, Inc.

LTUSLotus Pharmaceuticals, Inc.$0.00-4.17%

AWWIAlpha Wastewater, Inc.

AWWIAlpha Wastewater, Inc.$0.00+0.00%

IKTOiTokk, Inc.

IKTOiTokk, Inc.$0.00+0.00%

IGSCIGS Capital Group Limited

IGSCIGS Capital Group Limited$0.51+0.00%

BFYWBetter For You Wellness, Inc.

BFYWBetter For You Wellness, Inc.$0.00+0.00%

OHCSOptimus Healthcare Services, Inc.

OHCSOptimus Healthcare Services, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$15.46+0.03%

INTCIntel

INTCIntel$127.86+0.03%

NOKNokia

NOKNokia$14.82+0.00%

PAYOPayoneer Global

PAYOPayoneer Global$7.03+0.04%

PATHUiPath

PATHUiPath$10.79+0.02%

NUNu Holdings

NUNu Holdings$12.43+0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.89+0.02%

Questions About MNZO

What is the current price of Manzo Pharmaceuticals?

Manzo Pharmaceuticals is trading at $0.00 per share.

What is the 52-week range for Manzo Pharmaceuticals?

Over the past 52 weeks, Manzo Pharmaceuticals has traded between $0.00 and $0.00.

How much debt does Manzo Pharmaceuticals have?

As of the most recent reporting period, Manzo Pharmaceuticals reported total debt of $0.00.

How much cash does Manzo Pharmaceuticals have on hand?

Manzo Pharmaceuticals reported $113.15K in cash and cash equivalents in its most recent financial results.

What is Manzo Pharmaceuticals’s dividend yield?

Manzo Pharmaceuticals does not currently have a dividend yield.

Manzo Pharmaceuticals

Manzo Pharmaceuticals Financials at a Glance

MNZO News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Manzo Pharmaceuticals

MNZO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Manzo Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MNZO

What is the current price of Manzo Pharmaceuticals?

What is the 52-week range for Manzo Pharmaceuticals?

How much debt does Manzo Pharmaceuticals have?

How much cash does Manzo Pharmaceuticals have on hand?

What is Manzo Pharmaceuticals’s dividend yield?

Premium Investing Services